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Purpose: This study investigated the centrosomal protein, 290-KD (CEP290) associated genotype and ocular and extra-
ocular phenotype in 18 patients with Leber congenital amaurosis (LCA).
Methods: Eighteen patients with LCA from 14 families with mutations in the CEP290 gene were identified with
sequencing or with heteroduplex analysis. Ophthalmic examinations were performed on all patients. Scans of the central
nervous system were reassessed in three patients and obtained in two. Renal function was evaluated in all patients.
Ultrasonography of the kidneys was performed in six patients.
Results: Eight patients (from five families) carried the c.2991+1655A>G mutation homozygously. Nine solitary patients
carried this variant combined with a nonsense, frameshift, or splice site mutation on the second allele. One new nonsense
mutation was identified: c.1078C>T. Fourteen patients (from 12 families) had been completely blind from birth or had
light perception. The best-recorded visual acuity was 20/200. Peripheral fundus changes appeared to be progressive with
a relatively preserved posterior pole. Novel ophthalmic features for the CEP290 phenotype were Coats-like exudative
vasculopathy in two patients, a small chorioretinal coloboma in one patient, and well defined, small, atrophic spots at the
level of the retinal pigment epithelium causing a dot-like appearance in five patients. Some CEP290 patients exhibited
systemic abnormalities. We found abnormal proprioception in two patients and mild mental retardation in one. One patient
was infertile due to immobile spermatozoa. No renal abnormalities were detected.
Conclusions: CEP290-associated LCA has a severe, progressive, and clinically identifiable phenotype. Distinct extra-
ocular findings were noted, which may be attributed to ciliary dysfunction.
Leber congenital amaurosis (LCA) represents a group of
clinically and genetically heterogeneous retinal dystrophies
defined  by  severe  visual  dysfunction  at  birth,  sensory
nystagmus, a nondetectable electroretinogram (ERG), and an
autosomal recessive inheritance pattern [1,2]. LCA has an
estimated incidence of 1 in 30,000 newborns and a worldwide
prevalence of approximately 200,000 patients [3,4].
Eighteen causative genes for LCA are known (see B-
diseases),  and  mutations  in  these  genes  account  for
approximately 70% of all patients with LCA [5,6]. To date,
the most frequently mutated LCA gene is centrosomal protein,
290-KD  (CEP290)  [7,8],  which  encodes  a  protein
ubiquitously expressed in ciliated cells, including rods and
cones [9]. In addition to LCA, mutations in CEP290 can also
lead to Joubert syndrome [10,11], Senior-Loken syndrome
[10], the lethal disorder Meckel-Gruber syndrome [12,13],
and Bardet-Biedl syndrome [14]. These diseases are termed
ciliopathies, which form a group of overlapping phenotypes
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featuring developmental malformation of the brain, cystic
kidney disease or nephronophthisis, and retinal degeneration.
CEP290  mutations  account  for  6%–22%  of  non-
syndromic LCA, depending on the population studied [5,7].
The majority of patients with LCA with CEP290 mutations
carry the intronic mutation c.2991+1655A>G (p.Cys998X),
which with lymphoblast RNA analysis was found to introduce
a cryptic exon into the CEP290 mRNA, creating a stop codon
at the 5′ end of the insertion. However, only approximately
50% of the mRNA contained the cryptic exon, rendering this
variant a hypomorphic mutation, which subsequently may
influence the phenotypic outcome [7].
In  the  initial  report  on  CEP290-associated  LCA,  we
reported on intrafamilial variability with respect to visual
acuity in four Canadian patients, and the absence of extra-
ocular symptoms, except for seizures in two affected siblings
and  abnormal  proprioception  in  one  patient  [7].  Several
reports on the CEP290-associated phenotype have since been
published. Perrault et al. [8] described the phenotype as LCA
type 1 (cone-rod), characterized by some photo-aversion, high
hyperopia, severely reduced visual acuity (<20/400), and a
salt-and-pepper  aspect  of  the  fundus  with  macular
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412degeneration, resulting in a typical retinitis pigmentosa (RP)
appearance by the second decade. Coppieters and coworkers
also observed the CEP290 LCA phenotype as one of a severe
cone-rod  dystrophy  with  progressive  peripheral  fundus
changes, but with a relatively spared macular region [15].
Pasadhika et al. [16] studied the morphology of CEP290-
related  LCA  with  spectral  domain–optical  coherence
tomography  (SD-OCT).  They  showed  preservation  of  the
outer  nuclear  layer  (ONL)  with  a  poorly  defined
photoreceptor  inner/outer  segment  junction  and  with  a
distorted inner retina in the central macular area. The ocular
phenotype was further expanded by Littink and colleagues,
who reported on two patients with CEP290 mutations with
relatively  well  preserved  visual  acuity  (VA)  and  with
detectable scotopic responses on ERG, leading the authors to
diagnose  these  patients  with  early-onset  severe  retinal
dystrophy rather than LCA [17].
Several groups studied associated extra-ocular signs in
patients with LCA with CEP290 mutations. Perrault et al.
[8] observed transitory hypotonia, ataxia, mental retardation,
and  autistic  behavior  in  a  minority  of  their  patients  with
surprising  intra-familiar  discrepancies.  McEwen  and
coworkers  [9]  examined  other  ciliary-driven  sensory
dysfunctions,  and  discovered  olfactory  defects  in  retinal
degeneration 16 (rd16) mice, and subsequently in patients
with LCA with CEP290 mutations [18]. Coppieters et al.
[15]  reported  on  different  degrees  of  kidney  disease  and
neurologic  involvement  in  patients  carrying  the  same
CEP290 mutations. The researchers hypothesized that the
neurologic  phenotype  was  modified  by  the  presence  of
heterozygous  Abelson  Helper  Integration  sit  1  (AHI1)
mutations. Papon and colleagues [19] showed ultrastructural
defects in respiratory cilia in nasal biopsies and brushing on
seven patients with LCA with CEP290 mutations.
The goal of this study was to further delineate the ocular
phenotype of CEP290 LCA and to search for other extra-
ocular symptoms in a cohort of Dutch and Canadian patients.
In the current study of 18 patients, we were able to expand the
ophthalmic phenotype of CEP290-related LCA by Coats-like
exudative vasculopathy and chorioretinal coloboma as new
ophthalmic findings.
METHODS
Mutation analysis: DNA was extracted from peripheral blood
leukocytes using a salting-out procedure [20]. Patients were
tested for the c.2991+1655A>G CEP290 mutation with allele-
specific  PCR  [7]  or  with  the  newest  version  of  the  LCA
mutation chip (Asper Ophthalmics, Tartu, Estonia). After one
heterozygous  allele  was  identified,  all  53  CEP290 coding
exons  were  analyzed  with  bi-directional  sequencing  or
heteroduplex  analysis  (ABI3730  and  ABI3100  Genetic
Analyzers; Applied Biosystems, Inc. [ABI], Foster City, CA)
to  identify  the  second  allele.  Primer  sequences  and  PCR
conditions  were  described  previously  (Appendix  1)  [13].
Briefly, PCR amplification consisted of a denaturizing step at
95 °C for 5 min, followed by 35 cycles of amplification (95 °C
for 30 s, X °C for 30 s, 72 °C for 45 s) and a final extension
at 72 °C for 5 min. In two unrelated affected siblings, no blood
samples  were  drawn  at  request  of  the  parents;  however,
samples were available for the probands of these families.
Patients:  Eighteen  healthy  patients  were  recruited  at  The
Rotterdam  Eye  Hospital  and  the  Montreal  Children’s
Hospital. Written informed consent was obtained from the
patients with LCA or their legal representatives before blood
was  drawn.  The  procedures  were  approved  by  the  Ethics
Committees  of  the  Rotterdam  Eye  Hospital  and  McGill
University Health Centre and adhered to the Declaration of
Helsinki. Ten females and 8 males were included in this study
in an age range from 2 to 43 years. Eight patients of six
families (Patients 1, 2, 3, 4, 5, 6, 12, and 14) were part of a
cohort of patients with LCA whose molecular data, but not
clinical data, were described by den Hollander et al. [7]. The
other  ten  patients  were  suspected  of  carrying  CEP290
mutations based on their fundus appearance.
After mutations in CEP290 were identified, retrospective
data  were  studied,  and  all  18  patients  with  LCA  were
reexamined.  A  medical  history  was  taken  and  included
questions about the age of onset of ocular and potential extra-
ocular  symptoms.  The  history  also  included  questions
concerning pregnancy, birth, post-natal period, development,
consanguinity,  and  family  history.  Ophthalmologic
examinations included evaluation of the pupillary reaction
and nystagmus, best-corrected visual acuity (BCVA), and
objective  refractive  error  after  cycloplegia.  The  anterior
segments were examined with slit-lamp biomicroscopy, and
funduscopy  was  performed  after  pupillary  dilation.  In  all
patients, fundus photography attempts were made. Optical
coherence tomography (OCT) was obtained in four patients
(OCT3 Stratus; Carl Zeiss Meditec, Inc., Dublin, CA, and
Spectralis; Heidelberg Engineering, Heidelberg, Germany).
ERGs were performed according to International Society for
Clinical Electrophysiology of Vision standards [21]. Renal
function was studied with blood sample testing for potassium,
sodium,  creatinine  levels,  and  creatinine  clearance  in  all
patients. Renal ultrasounds were performed to evaluate kidney
architecture in six patients.
Signs  of  Joubert  syndrome  (e.g.,  lack  of  normal
decussation  of  superior  cerebllar  peduncular  fiber  tracts
[molar tooth sign]) were specifically studied in five patients.
In three patients, previously recorded images of the central
nervous  system  were  reevaluated  (magnetic  resonance
imaging [MRI] for two and computed tomography [CT] for
one), and in two other patients, MRIs were obtained.
RESULTS
Mutation analysis: The results of the molecular analyses are
summarized in Table 1. Fifteen patients were of Dutch descent
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413and three of French-Canadian descent. Three sibships were
included  from  three  (Patients  1–3)  and  two  affected
individuals (Patients 8 and 9, 16, and 17). Eight patients (from
five  families)  carried  the  c.2991+1655A>G  mutation
homozygously. Nine patients were compound heterozygotes
with  one  c.2991+1655A>G  mutation  and  a  nonsense,
frameshift or splice site mutation on the other allele. One new
CEP290  nonsense  mutations  was  identified:  c.1078C>T
(p.Arg360X;  Patient  15).  Patient  12  was  from  a
consanguineous marriage, but was compound heterozygous.
Consanguinity  was  five  generations  ago,  and  segregation
analysis showed the mother was a heterozygous carrier of the
R1272X mutation and the father of the c.2991+1655A>G
mutation. The genotype of Patients 1 (and his siblings 2 and
3), 4, 5, 6, 12, and 14 and the co-segregation of four of these
families were described by den Hollander et al. [7] as patients
21365, 21393, 20152, 21918, 17971, and 12832, respectively.
Clinical  findings:  Clinical  information  is  summarized  in
Table 2 except for the description of the retinal appearance
which  is  separately  summarized  in  Table  3.On  medical
history, all patients had roving eye movements, or nystagmus
with sluggishly pupillary reactions since early childhood. Eye
poking was present in 17 patients and enophthalmos in seven
patients (Patients 1, 2, 3, 5, 12, 13, and 17). Photophobia was
not recorded as an early symptom in patients with vision. Two
patients (Patients 2 and 15) developed photophobia later in
life. Three patients (Patients 7, 14, and 15) had a clear history
of night blindness.
In seven patients, no light perception was recorded. In
two, there was an indication of light perception in the past
(Patients 4 and 6). Sixteen eyes of nine patients (Patients 1, 2,
7, 8, 9, 13, 14, 15, and 18) perceived light only. In the other
patients, visual acuity varied from detecting hand motion (one
eye  of  Patient  13)  to  20/200  (one  eye  of  Patient  11).
Deterioration  of  visual  acuity  was  documented  in  three
patients over periods of 15 years or more (Patients 7, 11, and
15). Mild to high hyperopia (ranging from +2.00 to +12.00
diopters spherical equivalent) was a constant feature in the
majority of the patients (11 patients). One patient showed
myopia (Patient 15), possibly due to her cataract. Six patients
(Patients 6, 9, 10, 12, 16, and 18) had keratoconus. In five, this
was a bilateral finding. In one patient (Patient 6), ophthalmic
examination was not possible due to severe ectatic corneas
with vascular in-growth and bullous changes (Figure 1A). His
lenses  were  luxated  into  the  vitreous  cavity  (as  seen  on
ultrasonography).  Posterior  subcapsular  cataracts  were
observed in two patients (Patients 14 and 15) and an anterior
subcapsular cataract in one (Patient 7). Two patients were
pseudophakic (Patient 8 and 9), and one aphakic (Patient 10).
Seventeen  patients  were  available  for  funduscopy.  A
relatively pink optic disc was observed in 13 patients (Patients
1, 2, 3, 4, 8, 9, 10, 11, 12, 13, 16, 17, and 18; Figure 1B and
Figure 2A). In six (Patients 1, 3, 11, 13, 16, and 18), a distinct
yellowish scleral rim was observed (Figure 2A). Two patients
(Patients  1  and  7)  had  pseudo-papillary  edema  with
epipapillary fibrosis in one (Patient 7; Figure 3A). Another
patient (Patient 15) displayed a small chorioretinal coloboma
inferior to the optic disc unilaterally (Figure 4). Vessels were
mildly to moderately attenuated in all but one patient whose
vessels  were  dilated  (Patient  13).  One  patient  (Patient  7)
showed vascular sheathing on the optic disc (Figure 3A).
All 17 patients had a preserved posterior pole. The macula
and fovea were recognizable in all patients but without normal
reflexes. The right eye in Patient 18 was the only exception
TABLE 1. CEP290 MUTATIONS IN LEBER CONGENITAL AMAUROSIS PATIENTS.
    Allele 1 Allele 2
Patient number Origin Mutation Effect Mutation Effect
1$ Netherlands c.2991+1655A>G p.Cys998X c.2991+1655A>G p.Cys998X
2$ Netherlands c.2991+1655A>G p.Cys998X c.2991+1655A>G p.Cys998X
3$ Netherlands c.2991+1655A>G p.Cys998X c.2991+1655A>G p.Cys998X
4 Netherlands c.2991+1655A>G p.Cys998X c.265dupA p.Thr89AsnfsX1
5 Netherlands c.2991+1655A>G p.Cys998X c.679_680delGA p.Glu227SerfsX1
6 Netherlands c.2991+1655A>G p.Cys998X c.180+1G>T splice defect
7 Netherlands c.2991+1655A>G p.Cys998X c.5668G>T p.Gly1890X
8§ Canada c.2991+1655A>G p.Cys998X c.2991+1655A>G p.Cys998X
9§ Canada c.2991+1655A>G p.Cys998X c.2991+1655A>G p.Cys998X
10 Canada c.2991+1655A>G p.Cys998X c.2991+1655A>G p.Cys998X
11 Netherlands c.2991+1655A>G p.Cys998X c.5587–1G>C splice defect
12 Netherlands c.2991+1655A>G p.Cys998X c.3814C>T p.Arg1272X
13 Netherlands c.2991+1655A>G p.Cys998X c.2991+1655A>G p.Cys998X
14 Netherlands c.2991+1655A>G p.Cys998X c.2991+1655A>G p.Cys998X
15 Netherlands c.5587–1G>C splice defect c.1078C>T p.Arg360X
16¶ Netherlands c.2991+1655A>G p.Cys998X c.3175dup p.Ile1059fs
17¶ Netherlands NT   NT  
18 Netherlands c.4661_4663del p.Glu1544del c.1645C>T p.Arg549X
          *: Previously genotyped by den Hollander et al. [7]; $§¶: sibships; NT: not tested on request of parents.
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s
 
B
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1
7
¶
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2
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M
N
L
P
N
L
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+
2
.
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3
.
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o
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1
8
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1
7
)
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L
P
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P
N
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t
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o
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s
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*
:
 
P
r
e
v
i
o
u
s
l
y
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e
n
o
t
y
p
e
d
 
b
y
 
d
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n
 
H
o
l
l
a
n
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e
r
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l
.
 
[
7
]
;
 
$
§
¶
:
 
s
i
b
s
h
i
p
s
;
 
A
S
C
:
 
a
n
t
e
r
i
o
r
 
s
u
b
c
a
p
s
u
l
a
r
;
 
B
E
:
 
b
o
t
h
 
e
y
e
s
;
 
C
F
:
 
c
o
u
n
t
i
n
g
 
f
i
n
g
e
r
s
;
 
C
T
:
 
c
o
m
p
u
t
e
d
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
t
o
m
o
g
r
a
p
h
y
;
 
E
E
G
:
 
e
l
e
c
t
r
o
e
n
c
e
p
h
a
l
o
g
r
a
p
h
y
;
 
F
:
f
e
m
a
l
e
;
 
H
M
:
 
h
a
n
d
 
m
o
t
i
o
n
;
 
L
C
A
:
 
L
e
b
e
r
 
c
o
n
g
e
n
i
t
a
l
 
a
m
a
u
r
o
s
i
s
;
 
L
E
:
 
l
e
f
t
 
e
y
e
;
 
L
P
:
 
l
i
g
h
t
 
p
e
r
c
e
p
t
i
o
n
;
 
M
:
 
m
a
l
e
;
 
N
A
:
 
n
o
t
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a
c
c
e
s
s
i
b
l
e
 
f
o
r
 
e
x
a
m
i
n
a
t
i
o
n
;
 
N
L
P
:
 
n
o
 
l
i
g
h
t
 
p
e
r
c
e
p
t
i
o
n
;
 
P
S
C
:
 
p
o
s
t
e
r
i
o
r
 
s
u
b
c
a
p
s
u
l
a
r
;
 
R
E
:
 
r
i
g
h
t
 
e
y
e
;
 
R
P
E
:
 
r
e
t
i
n
a
l
 
p
i
g
m
e
n
t
 
e
p
i
t
h
e
l
i
u
m
;
 
S
E
:
 
s
p
h
e
r
i
c
a
l
 
e
q
u
i
v
a
l
e
n
t
;
 
y
:
 
a
g
e
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
o
f
 
e
x
a
m
i
n
a
t
i
o
n
 
i
n
 
y
e
a
r
s
.
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p
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c
l
e
r
a
l
 
r
i
m
,
 
p
s
e
u
d
o
p
a
p
i
l
l
a
r
y
 
e
d
e
m
a
;
 
v
e
s
s
e
l
s
:
 
m
i
l
d
l
y
 
a
t
t
e
n
u
a
t
e
d
;
 
p
o
s
t
e
r
i
o
r
 
p
o
l
e
:
 
p
r
e
s
e
r
v
e
d
 
R
P
E
,
 
m
i
l
d
 
w
r
i
n
k
l
i
n
g
 
I
L
M
,
 
r
e
c
o
g
n
i
z
a
b
l
e
 
f
o
v
e
a
 
w
i
t
h
o
u
t
 
r
e
f
l
e
x
e
s
;
 
(
m
i
d
-
)
p
e
r
i
p
h
e
r
y
:
 
d
o
t
-
l
i
k
e
 
a
t
r
o
p
h
y
 
a
t
 
R
P
E
 
l
e
v
e
l
,
 
s
u
b
t
l
e
 
R
P
E
 
c
h
a
n
g
e
s
,
 
b
o
n
e
-
s
p
i
c
u
l
e
s
*
2
$
 
(
1
8
)
o
p
t
i
c
 
d
i
s
c
:
 
p
i
n
k
;
 
v
e
s
s
e
l
s
:
 
m
o
d
e
r
a
t
e
l
y
 
a
t
t
e
n
u
a
t
e
d
;
 
p
o
s
t
e
r
i
o
r
 
p
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l
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p
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l
e
:
 
r
e
l
a
t
i
v
e
l
y
 
h
y
p
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r
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p
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c
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p
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l
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R
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r
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p
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p
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l
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p
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p
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p
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p
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p
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e
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u
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e
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p
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p
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c
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p
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p
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p
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l
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p
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i
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l
i
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e
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e
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e
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p
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p
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p
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p
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p
r
e
s
e
r
v
e
d
 
R
P
E
 
m
a
c
u
l
a
r
 
r
e
g
i
o
n
,
 
r
e
c
o
g
n
i
z
a
b
l
e
 
f
o
v
e
a
,
 
n
o
 
r
e
f
l
e
x
e
s
,
 
m
i
l
d
 
e
p
i
r
e
t
i
n
a
l
 
m
e
m
b
r
a
n
e
 
R
E
;
 
(
m
i
d
-
)
p
e
r
i
p
h
e
r
y
:
 
(
l
o
b
u
l
a
r
)
 
a
t
r
o
p
h
y
 
R
P
E
,
 
s
o
m
e
 
b
o
n
e
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p
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p
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k
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e
d
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p
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p
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d
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e
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r
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r
e
f
l
e
x
e
s
,
 
w
r
i
n
k
l
i
n
g
 
I
L
M
 
(
B
E
)
,
 
y
e
l
l
o
w
 
d
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c
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p
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e
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p
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p
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r
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u
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e
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p
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l
e
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e
x
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p
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r
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t
i
n
a
l
 
d
e
t
a
c
h
m
e
n
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(
4
5
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o
p
t
i
c
 
d
i
s
c
:
 
m
o
d
e
r
a
t
e
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l
l
o
r
;
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e
s
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e
l
s
:
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e
v
e
r
e
l
y
 
a
t
t
e
n
u
a
t
e
d
;
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o
s
t
e
r
i
o
r
 
p
o
l
e
:
 
p
r
e
s
e
r
v
e
d
 
R
P
E
,
 
f
o
v
e
a
 
r
e
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o
g
n
i
z
a
b
l
e
,
 
n
o
 
r
e
f
l
e
x
e
s
;
 
(
m
i
d
-
)
 
p
e
r
i
p
h
e
r
y
:
 
(
l
o
b
u
l
a
r
)
 
R
P
E
 
a
t
r
o
p
h
y
,
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o
n
e
-
s
p
i
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u
l
e
s
1
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(
3
8
)
o
p
t
i
c
 
d
i
s
c
:
 
m
i
l
d
 
p
a
l
l
o
r
;
 
v
e
s
s
e
l
s
:
 
m
o
d
e
r
a
t
e
l
y
 
a
t
t
e
n
u
a
t
e
d
;
 
p
o
s
t
e
r
i
o
r
 
p
o
l
e
:
 
p
r
e
s
e
r
v
e
d
 
R
P
E
,
 
s
u
b
t
l
e
 
R
P
E
 
c
h
a
n
g
e
s
,
 
E
R
M
;
 
(
m
i
d
-
)
 
p
e
r
i
p
h
e
r
y
:
 
c
h
o
r
i
o
r
e
t
i
n
a
l
 
c
o
l
o
b
o
m
a
 
R
E
,
 
(
l
o
b
u
l
a
r
)
 
a
t
r
o
p
h
y
R
P
E
,
 
b
o
n
e
-
s
p
i
c
u
l
e
s
,
 
p
a
v
i
n
g
-
s
t
o
n
e
 
d
e
g
e
n
e
r
a
t
i
o
n
 
3
6
0
 
d
e
g
r
e
e
s
1
6
¶
 
(
4
)
o
p
t
i
c
 
d
i
s
c
:
 
p
i
n
k
,
 
s
c
l
e
r
a
l
 
r
i
m
;
 
v
e
s
s
e
l
s
:
 
m
i
l
d
l
y
 
a
t
t
e
n
u
a
t
e
d
;
 
p
o
s
t
e
r
i
o
r
 
p
o
l
e
:
 
p
r
e
s
e
r
v
e
d
 
R
P
E
,
 
m
a
c
u
l
a
:
 
r
e
l
a
t
i
v
e
l
y
 
d
a
r
k
 
a
s
p
e
c
t
;
 
(
m
i
d
-
)
 
p
e
r
i
p
h
e
r
y
:
 
t
a
p
e
t
a
l
 
r
e
f
l
e
x
,
 
s
u
b
t
l
e
 
h
y
p
o
-
a
n
d
h
y
p
e
r
p
i
g
m
e
n
t
e
d
 
a
r
e
a
s
1
7
¶
 
(
2
)
o
p
t
i
c
 
d
i
s
c
:
 
p
i
n
k
;
 
v
e
s
s
e
l
s
:
 
m
i
l
d
l
y
 
a
t
t
e
n
u
a
t
e
d
;
 
p
o
s
t
e
r
i
o
r
 
p
o
l
e
:
 
p
r
e
s
e
r
v
e
d
 
R
P
E
;
 
(
m
i
d
-
)
 
p
e
r
i
p
h
e
r
y
:
 
t
a
p
e
t
a
l
 
r
e
f
l
e
x
,
 
g
r
a
n
u
l
a
r
 
a
s
p
e
c
t
1
8
 
(
1
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)
o
p
t
i
c
 
d
i
s
c
:
 
p
i
n
k
,
 
s
c
l
e
r
a
l
 
r
i
m
;
 
v
e
s
s
e
l
s
:
 
m
o
d
e
r
a
t
e
l
y
 
a
t
t
e
n
u
a
t
e
d
;
 
p
o
s
t
e
r
i
o
r
 
p
o
l
e
:
 
p
r
e
s
e
r
v
e
d
 
R
P
E
,
 
s
u
b
t
l
e
 
R
P
E
 
c
h
a
n
g
e
s
 
m
a
c
u
l
a
,
 
p
r
e
s
e
n
t
 
f
o
v
e
o
l
a
r
 
r
e
f
l
e
x
 
R
E
,
 
a
b
s
e
n
t
 
L
E
;
 
(
m
i
d
-
)
 
p
e
r
i
p
h
e
r
y
:
R
P
E
 
a
t
r
o
p
h
y
,
 
b
o
n
e
-
s
p
i
c
u
l
e
s
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P
r
e
v
i
o
u
s
l
y
 
g
e
n
o
t
y
p
e
d
 
b
y
 
d
e
n
 
H
o
l
l
a
n
d
e
r
 
e
t
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416because it showed a foveal reflex. The macular region was
relatively darker pigmented compared to the surrounding RPE
in three patients (Patients 3, 12, and 16) (Figure 2A). In four
patients  (Patients  7,  10,  15,  and  18),  the  macular  region
displayed subtle RPE changes. In six patients (Patients 1, 3,
4,  11,  12,  and  15),  mild  wrinkling  of  the  inner  limiting
membrane with or without epiretinal fibrosis was noted.
Two  patients  did  not  have  peripheral  RPE  changes
(Patient 9 aged 16 and Patient 12 aged 9). In five patients,
including a sibship of three affected (Patients 1, 2, 3, 10, and
13), small atrophic spots at the level of the RPE that imposed
as dot-like changes were noted in the periphery combined with
a granular aspect of the RPE (Figure 2B). Three of these
patients (Patients 2, 3, and 13) also displayed some intra-
retinal pigmentations. A striking greyish white, patchy tapetal
reflex was seen in the (mid-) periphery in three young patients
(Patients 4, 16, and 17; Figure 5A,B). One (Patient 16) had
hypo- and hyper-pigmented areas in the far periphery whereas
her younger brother (Patient 17) did not. In the remaining
patients (Patients 5, 7, 8, 11, 14, 15, and 18) ranging in age
Figure 1. Ophthalmic features of Patient 6. A: External appearance of the right eye at age 43. Note the ectatic white cornea. B: Fundus
photograph of the right eye of the same patient at the age of six months. Note the normal fundus features.
Figure 2. Fundus photographs of the right eye of Patient 3 at age 13. A: Note the pink optic disc with scleral rim, mild attenuation of vessels,
and preservation of the RPE in the posterior pole, with greyish, darker appearance of the macula with subtle wrinkling of the inner limiting
membrane. B: Note the subtle, atrophic, well defined dot-like changes at the level of the RPE and the bone spicules in the periphery.
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417from five to 39, RPE atrophy was more pronounced with bone
spicule-like pigmentations.
Two patients (Patients 7 and 13) were treated for Coats-
like exudative vasculopathy. Patient 7 presented with Coats-
like exudative changes in the left eye at the age of 31 and
developed telangiectatic vessels in the inferior quadrants of
the right eye at the age of 38 (Figure 3B). The other patient
(Patient 13) returned a year after her last check-up because of
photopsia and was found to have exudative detachments with
tortuous, dilated vessels in the inferior quadrants of both eyes
at the age of 18.
Goldmann  perimetry  was  performed  in  two  patients
(Patients 7 and 11) and revealed central visual fields of less
than 5° using the largest target (V-4e). ERG responses were
nondetectable in all patients. OCT images revealed normal-
appearing retinal layers in Patient 12 (Figure 6), whereas
thinned photoreceptor and outer nuclear layers were observed
in two patients with deep foveal pits (Patients 7 and 14) and
cyst-like changes in one of them (Patient 7; Figure 3C). These
cysts  were  not  noted  on  funduscopy.  In  another  patient
(Patient 11), the thickness of the retinal layers seemed normal,
but foveal depression was lacking.
The motor and intellectual development in 16 patients
was reported and documented as normal when compared to
other blind children. None of our patients had a hearing deficit,
polydactyly,  or  obesity.  Olfactory  dysfunction  was  not
reported.  Two  patients  (Patients  4  and  6)  had  abnormal
proprioception,  and  one  had  mild  mental  retardation.  No
abnormalities suggestive of Joubert syndrome were present
on MRI, although minor anomalies were seen in one patient
Figure 3. Fundus photographs and OCT of Patient 7 at age 39. A: Note the pseudopapillary edema, vascular sheathing, preserved RPE in the
posterior pole, subtle RPE changes in the macula, and the pronounced RPE and choriocapillary atrophy with bone spicule-like pigmentations
along the vascular arcade in the right eye. B: Note the exudation in the posterior pole with shallow detachment in the left eye. C: Spectralis
optical coherence tomography (OCT) image of the macular region of the right eye showing cyst-like changes (*) in the outer nuclear layer
with preservation of the inner/outer segment junction under the fovea but absent in the parafoveal region. Note the thinning of the outer nuclear
layer at the center (arrow).
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418with  normal  intelligence  (Patient  4).  Neuro-imaging  in
another four patients (Patients 1, 5, 7, and 12) did not reveal
any  abnormalities  of  the  central  nervous  system.
Electroencephalography abnormalities were recorded in the
past  in  one  patient  (Patient  15)  for  which  she  received
treatment with antiepileptic drugs.
All  patients  had  normal  renal  function  on  laboratory
testing. No signs of cystic kidney disease were detected on
ultrasonography in the patients (Patients 1, 4, 5, 6, 7, and 12)
tested.
Three male patients were of reproductive age. Two did
not have offspring: one had mental retardation (Patient 6), and
the  other  one  (Patient  7)  was  infertile  due  to  immobile
spermatozoa. Patient 11 had hypofertility but had conceived
offspring naturally.
DISCUSSION
The goal of the current study was to investigate ocular specific
characteristics  and  extra-ocular  features  in  patients  with
CEP290-related LCA.
In our cohort of 18 patients, we found one new nonsense
mutation (Patient 15; c.1078C>T [p.Arg360X]) in CEP290.
The  most  frequently  encountered  CEP290  mutation  in
patients  of  European  descent  with  LCA  [7,8],  the  c.
2991+1655A>G mutation, was detected in 22 of 34 alleles (of
14  families)  tested.  Almost  half  of  the  patients  carried  a
homozygous c.2991+1655A>G mutation. One third of the
patients  had  this  mutation  combined  with  a  nonsense,
frameshift, or splice site mutation on the other allele. In only
two patients, the founder mutation was not detected, but the
ocular phenotype of these patients was identical to the other
patients.
Because of the relative large number of patients with
LCA with CEP290 mutations in the present study spread over
different age groups, we were able to study different stages of
the disease. Although there was some inter- and intrafamilial
variability,  the  patients  showed  a  relatively  homogenous
distinctive  phenotype.  We  found  frequently  occurring
symptoms as in other forms of LCA, such as eye poking,
enophthalmos,  nystagmus,  sluggish  pupillary  reflexes,
hyperopia, keratoconus, and juvenile cataracts [22,23]. Visual
acuity  in  the  majority  of  the  patients  was  either  light
perception or no vision at all from birth. In the small group of
patients with visual acuity equal to or more than hand motion,
we were able to record progressive deterioration of visual
acuity in succeeding years. Although we did not perform a
longitudinal study, with retrospective data analysis (including
fundus  color  photographs),  we  established  an  increase  in
degenerative changes on funduscopy, from no changes to
small, well defined, atrophic spots at the level of the RPE (dot-
like) to more pronounced RPE atrophy with intraretinal bone
spicule-like pigmentations and a preserved macular region as
in RP. Based on VA loss and progressive retinal changes over
time, we conclude that LCA caused by CEP290 mutations is
a progressive retinal dystrophy.
Figure 4. Fundus photograph of the right
eye of Patient 15 at age 38. Note the mild
pallor of the optic disc, the attenuation
of  the  vessels,  the  chorioretinal
coloboma,  the  retinal  pigment
epithelium atrophy (RPE) atrophy, and
the bone spicule-like pigmentations.
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419Perrault et al. [8] and Coppieters et al. [15] classified
CEP290  associated  LCA  as  a  cone-rod  retinal  dystrophy.
Whereas no ERG data were available in the first, the latter
mentioned severe cone-rod disease on ERG testing in three
out of 27 patients with LCA and CEP290 mutations. Littink
and  colleagues  [17]  observed  two  patients  with  CEP290
mutations, relatively well preserved VA (up to 20/40), and
only detectable rod function and no cone function on ERG.
Although we did not have recordable ERG responses in any
of  the  patients  studied,  our  clinical  data  of  progressive
peripheral retina changes and a relatively spared macula even
in late stages of the disease suggest that the patients in this
cohort had a progressive rod-cone type of disease rather than
a cone-rod one.
We were able to get spectral domain–optical coherence
tomography (SD-OCT) in four of our patients. Thinning of
the ONL and the photoreceptor layer was found in two. The
other patients displayed normal retinal layers at the macula
(Figure 6); however, the foveal pit was absent in one. Other
OCT  studies  in  LCA  CEP290  patients  also  showed  the
presence of all retinal layers [17]. Pasadhika et al. [16] showed
that  the  photoreceptor  inner/outer  segment  juncture  was
poorly defined in the central macula whereas this junction was
invisible in the periphery. A retained ONL was found in the
central macular area of most patients that was more prominent
at younger age. Inner retinal structures were distorted, and
about half of the studied patients had cystlike lesions in the
inner  retina,  similar  to  one  of  our  patients  (Figure  3C).
Figure 5. Fundus photographs of the right eye (A) and left eye (B) of Patient 16 at age 4. The optic nerve is pink with mild attenuation of the
vessels and a preserved macula. Note the grayish white, patchy, tapetal reflex in the midperiphery.
Figure 6. Spectralis OCT of the right eye of Patient 12 at age 9. Note the intact and normal thickness of all retinal layers.
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420Cideciyan et al. [24] performed a retinal micro-anatomic OCT
study  and  revealed  a  relatively  preserved  foveal  cone
photoreceptor lamination and detectable subjacent RPE in
patients with LCA and CEP290 mutations, independent of
severity  of  visual  loss.  The  sparing  of  cones,  however,
decreased with aging, suggesting that CEP290 mutant central
retinas  show  slowly  progressive  degeneration  of  cones.
Cideciyan et al. [24] also found that cone cell death seemed
considerably slower than the loss of rods, suggesting different
roles of CEP290 in the two photoreceptor populations. These
findings  all  further  support  our  impression  that  from  a
morphological  perspective  in  fact  this  type  of  retinal
dystrophy might be a rod-cone disease.
As  for  the  retinal  appearance,  in  three  patients  we
observed a striking tapetal reflex, consisting of intraretinal
greyish  white  marbled  areas.  In  the  younger  siblings,  the
tapetal reflex was more pronounced than in the older patient,
suggesting the possibility of a transient phenomenon, which
was also documented by Littink et al. [17]. One of these
patients carried the intron mutation homozygously whereas
the other was a compound heterozygote. Perrault et al. [8]
depicted the same feature in one of their patients carrying the
c.2991+1655A>G mutation homozygously.
The small atrophic spots at the RPE layer and the tapetal
reflex–like  changes  seem  specific  to  CEP290-associated
LCA, since they have not been described in other forms of
LCA. Another new observation was a distinct yellow scleral
rim and pseudopapillary edema in a subset of patients. A
scleral ring is a relatively common finding in RP [25] and RP-
related disorders but seems suggestive of this specific type of
LCA.
Two  of  our  patients  developed  bilateral  Coats-like
exudative vasculopathy, a rare complication in patients with
RP (1.2%–3.6%) and frequently associated with juvenile RP
caused  by  Crumbs  like  1  gene  (CRB1)  mutations  [26].
However, Coats-like exudative vasculopathy has never been
described in LCA. In a review paper, Kahn et al. [27] referred
to a report on LCA and Coats-like disease. In retrospect, this
report represents a family with early-onset RP. Our finding of
bilateral Coats reaction in two patients (both homozygous for
the  c.2991+1655A>G  mutation)  suggests  mutations  in
CEP290  might  predispose  for  this  type  of  complication.
Senior-Loken  syndrome,  which  can  also  be  caused  by
CEP290 mutations [10], has also been shown to be associated
with Coats-like disease [28].
Another new finding was the chorioretinal coloboma in
one of our patients who did not carry the founder mutation.
The  occurrence  of  a  developmental  coloboma  may  be
coincidental but was reported before in a Dutch patient with
Joubert  syndrome  [29]  for  whom  no  molecular  data  are
available.
Concerning the extra-ocular symptoms, one of our male
patients  (Patient  7)  was  infertile  due  to  immobile
spermatozoa, and one patient was hypofertile, presumably due
to asthenospermia. This finding was reported previously [19]
in a compound heterozygous CEP290 LCA patient. It seems
logical to assume that CEP290 mutations may cause abnormal
sperm tails and velocity. The observation that axonemes of
spermatozoa were abnormal in groups of patients with X-
Linked RP [30] and Usher syndrome [31] was made more than
20 years ago before the identification of ciliary genes, such as
retinitis pigmentosa type 1(RP1), retinitis pigmentosa GTPase
regulator  gene  (RPGR),  retinitis  pigmentosa  GTPase
regulator-interacting  protein  (RPGRIP1),  and  the  Usher
syndrome genes [32]. Infertility in mice with overexpression
of RPGR has been reported recently [33]. Since other cilia-
driven  problems  were  proven,  such  as  ultrastructural
respiratory cilia defects and olfactory dysfunction in patients
with  CEP290  mutations  and  heterozygote  carriers  [19],
further investigation of sperm abnormalities in male patients
and male heterozygotes would be interesting.
Abnormalities of the central nervous system such as the
molar tooth sign in Joubert syndrome were excluded in five
of our patients including two patients with balance difficulties
one of whom had mild mental retardation. These two ataxic
patients had the c.2991+1655A>G mutation combined with a
severe mutation (frame shift or a splice site) on the other allele.
Perrault and coworkers also found mental retardation and/or
autistic disorders in three CEP290-associated LCA families
with  homozygous  or  compound  heterozygous  frameshift
mutations. One family had the molar tooth sign, whereas
neuro-imaging was not available for the other two families
[8].  No  abnormalities  suggestive  of  renal  disease  were
detected in our cohort, and no renal cysts were found in the
six patients tested.
Altogether,  in  our  study  CEP290-LCA  seemed  to  be
associated with a predominantly ocular phenotype. Although,
we did not examine all our patients in depth for other possible
extra-ocular  features  such  as  anosmia  and  respiratory
dysfunction, indicating aberrant ciliary functioning. Patients
homozygous  for  the  hypomorphic  c.2991+1655A>G
mutation might have more residual protein than patients with
compound  heterozygous  mutations,  and  therefore  might
present with a less severe disease [7]. In this cohort of patients,
however,  visual  acuity  was  best  in  patients  who  were
compound heterozygotes, and extra-ocular features occurred
in  homozygous  (mental  retardation)  and  in  compound
heterozygous  patients  (ataxia,  mental  retardation,  and
infertility). Therefore, other genetic variants may modify the
phenotype as described by Leitsch et al. [14], who reported
on a Bardet-Biedl syndrome (BBS) patient with homozygous
CEP290 mutations and one heterozygous mutation in another
ciliary  BBS  gene  (Meckel  syndrome  type  3  [MKS3]).
Recently,  Coppieters  and  colleagues  hypothesized  the
influence of heterozygous AHI1 mutations on the CEP290
LCA  phenotype.  Khanna  et  al.  [34]  demonstrated  that  a
polymorphic coding variant in retinitis pigmentosa GTPase
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421regulator-interacting protein-1 like (RPGRIP1L) influences
the development of retinal degeneration in individuals with
ciliopathies caused by mutations in other genes. Therefore,
the predictive value of the genotype seems more complicated
than generally assumed and probably depends on the degree
of complex disruptions.
With the recent promising developments in human gene
replacement therapy in LCA caused by RPE65 mutations
[35-37],  treatment  options  for  LCA  caused  by  CEP290
mutations may become available in the future. Since this form
of  LCA  occurs  frequently,  the  accompanying  phenotype
should be recognized. We conclude that the LCA phenotype
resulting from CEP290 mutations in a Dutch and French-
Canadian cohort is a severe, slowly progressive form of LCA
with a clinically identifiable ocular phenotype. The phenotype
consists of a relative normal optic disc with scleral ring, mild
or moderate attenuation of the vessels, a relatively preserved
posterior pole, and some mild lobular RPE atrophy without
obvious bone spicules in the periphery that progresses with
aging. New clinical ocular findings were small, atrophic RPE
spots, Coats-like exudative vasculopathy, and chorioretinal
coloboma.  A  tapetal  reflex  was  observed  as  a  possible
transient phenomenon. New interesting extra-ocular findings
were immotile spermatozoa and ataxia. Extra-ocular findings
in patients with LCA with CEP290 mutations are relatively
frequent and mutation independent.
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424Appendix 1. Sequences and PCR conditions of CEP290.
Abbreviations:  °C  represents  degrees  celcius;  bp
represents base pairs; F represents forward; MgCl2 represents
magnesium; chloride; R represents reverse. To access the
data, click or select the words “Appendix 1.” This will initiate
the download of a compressed (pdf) archive that contains the
file.
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